Literature DB >> 32171041

Immunotherapy as a Downstaging Therapy for Liver Transplantation.

Birgit Schwacha-Eipper1,2, Iulia Minciuna1, Vanessa Banz2, Jean François Dufour1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32171041     DOI： 10.1002/hep.31234

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

1.  Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy.

Authors:  Xiaobo Yang; Haifeng Xu; Bangyou Zuo; Xu Yang; Jin Bian; Junyu Long; Dongxu Wang; Junwei Zhang; Cong Ning; Yanyu Wang; Ziyu Xun; Yunchao Wang; Xin Lu; Yilei Mao; Xinting Sang; Haitao Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2021-08       Impact factor: 7.293

Review 2.  Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.

Authors:  Nitin N Katariya; Blanca C Lizaola-Mayo; David M Chascsa; Emmanouil Giorgakis; Bashar A Aqel; Adyr A Moss; Pedro Luiz Serrano Uson Junior; Mitesh J Borad; Amit K Mathur
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

3.  Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy.

Authors:  Yalda Dehghan; Gabriel T Schnickel; Mojgan Hosseini; Adam M Burgoyne; Veeral H Ajmera; Gerald P Morris; Michel H Mendler; Justin R Parekh; Farid Abushamat; Irine Vodkin; Yuko Kono
Journal:  Clin J Gastroenterol       Date:  2021-10-13

4.  Immune Checkpoint Inhibitor Therapy Before Liver Transplantation-Case and Literature Review.

Authors:  Elizabeth S Aby; John R Lake
Journal:  Transplant Direct       Date:  2022-03-10

Review 5.  Immunotherapy and Gene Therapy: New Challenges in the Diagnosis and Management of Drug-Induced Liver Injury.

Authors:  Bénédicte Delire; Eleonora De Martin; Lucy Meunier; Dominique Larrey; Yves Horsmans
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

Review 6.  Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates.

Authors:  Shun Kawashima; Kole Joachim; Maen Abdelrahim; Ala Abudayyeh; Kenar D Jhaveri; Naoka Murakami
Journal:  Korean J Transplant       Date:  2022-06-03

7.  Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Authors:  Zi-Yun Qiao; Zi-Jie Zhang; Zi-Cheng Lv; Huan Tong; Zhi-Feng Xi; Hao-Xiang Wu; Xiao-Song Chen; Lei Xia; Hao Feng; Jian-Jun Zhang; Qiang Xia
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 7.561

Review 8.  Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.

Authors:  Yi Luo; Fei Teng; Hong Fu; Guo-Shan Ding
Journal:  World J Gastrointest Oncol       Date:  2022-01-15

Review 9.  Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation.

Authors:  Marco Biolato; Tiziano Galasso; Giuseppe Marrone; Luca Miele; Antonio Grieco
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

Review 10.  Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.

Authors:  Qimeng Gao; Imran J Anwar; Nader Abraham; Andrew S Barbas
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.